🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › Connecticut

Etid klinik pou Sendwòm myelodisplastik nan Connecticut

10 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan Connecticut.

Vil nan Connecticut

Tèks ofisyèl etid la (Anglè)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Yale University, New Haven
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Smilow Cancer Hospital at Yale-New Haven, New Haven
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06499285

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

  • Yale University, Yale Cancer Center, New Haven
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06656494

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

  • Connecticut Children's Medical Center, Hartford
Ap rekriteEtid obsèvasyon
Jiska laj 30 · Tout sèks · Mizajou Jul 16, 2026 · NCT04968834

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

  • GSK Investigational Site, New Haven
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 2, 2026 · NCT06847867

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Yale University, New Haven
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Hartford
  • Massive Bio SYNERGY-AI site, Norwalk
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.